Strike Three, Yer Out! FDA Bans Drug Products from Third Wockhardt Plant in India
Strike Three, Yer Out! FDA Bans Drug Products from Third Wockhardt Plant in India
Attachment: india
SUGAR LAND--August 12, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--In a situation that has gone from bad to worse, the U.S. Food and Drug Administration (FDA) has issued Indian drugmaker Wockhardt (Mumbai) an import alert against it manufacturing plant at Ankleshwar. The site, which manufactures active pharmaceutical ingredients (APIs), received a Form 483 following an unfavorable FDA inspection last year.
Within this article: Describes the regulatory actions in 2013 taken by the FDA that spurred the fall of Wockhardt.
POP
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips